SOUTH KOREA REACHES DEAL TO BUY ASTRAZENECA’S COVID-19 VACCINE CANDIDATE
South Korea has reached a deal with AstraZeneca PLC to purchase its coronavirus vaccine candidate as it seeks to secure supplies amid a resurgence of outbreaks.
The government has said it was in final talks with global drugmakers including AstraZeneca, Pfizer Inc and Johnson & Johnson over their experimental vaccines, and launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval.
According to JoongAng llobo nespaper, health authorities signed a contract with the Britain-based company on Nov. 27, and were nearing agreements with Pfizer and Johnson & Johnson, citing an unidentified government official.
“The AstraZeneca deal has been done, and a memorandum of understanding was reached with both Pfizer and Johnson & Johnson. But further negotiations are needed to finalize the amount of supplies and the timing of shipment,” the official was quoted as saying.